Literature DB >> 4631040

Defects and disabilities of thalidomide children.

R W Smithells.   

Abstract

The range of defects and disabilities in thalidomide children is very much wider than is generally realized. The defects of 154 children are described and classified. Their disabilities range from incapacitating to negligible.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4631040      PMCID： PMC1588044          DOI： 10.1136/bmj.1.5848.269

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  1 in total

1.  Thalidomide and malformations in Liverpool.

Authors:  R W SMITHELLS
Journal:  Lancet       Date:  1962-06-16       Impact factor: 79.321
  1 in total
  16 in total

1.  Challenges to the economic evaluation of new biotechnological interventions in healthcare.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

2.  Recognition of thalidomide defects.

Authors:  R W Smithells; C G Newman
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

3.  Four limb phocomelia.

Authors:  Vinod H Ratageri; T A Shepur
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

Review 4.  Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.

Authors:  M T Miller
Journal:  Trans Am Ophthalmol Soc       Date:  1991

5.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

6.  Refractive evaluation in thalidomide embryopathy.

Authors:  K Strömland; M T Miller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 7.  What can we learn from the thalidomide experience: an ophthalmologic perspective.

Authors:  Marilyn T Miller; Kerstin K Strömland
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

8.  A reappraisal of the CHARGE association.

Authors:  C A Oley; M Baraitser; D B Grant
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

9.  Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus. I. Effects of 3-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine (EM12) on skeletal development.

Authors:  H J Merker; W Heger; K Sames; H Stürje; D Neubert
Journal:  Arch Toxicol       Date:  1988-01       Impact factor: 5.153

10.  Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation.

Authors:  Christina Therapontos; Lynda Erskine; Erin R Gardner; William D Figg; Neil Vargesson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.